Scroll
To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

*Important

The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.


Debra of America, Inc. (Dystrophic Epidermolysis Bullosa)


Address

75 Broad Street
Suite 300
New York, NY 10004

Phone

2128681573

Fax

2128689296

800 Number

8663327276

Email Address

staff@debra.org

Description

Debra of America, Inc. (Dystrophic Epidermolysis Bullosa) is a national voluntary health organization dedicated to achieving a cure for epidermolysis bullosa (EB) and improving the care and quality of life for people with this disorder and their families. EB is a group of genetic disorders in which there is a defect causing the skin layers to separate and blister either spontaneously or at the slightest friction. Symptoms usually are apparent at or shortly after birth. The association promotes and supports scientific research on the cause, diagnosis, treatment, and cure of this disorder. DEBRA seeks to meet the unique needs of affected individuals and their families through programs that supply information, assistance, support, and guidance. DEBRA is also committed to raising public awareness about the nature of epidermolysis bullosa and to representing the special concerns of affected individuals and their families to government officials. The organization offers a variety of educational materials.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.